Congenital coagulation factor V deficiency with intracranial hemorrhage - PubMed

Review

doi: 10.1002/jcla.24705. Epub 2022 Sep 20.

Background: Congenital coagulation factor V (FV) deficiency is a very rare hemorrhagic disease with an incidence of approximately one in a million. The common clinical manifestations of FV deficiency include ecchymosis and mucosal bleeding. Life-threatening intracranial bleeding is rare. It has been reported in several cases. However, the molecular basis has been established in only a few cases.

Methods: We reported a 2-month-old girl with congenital FV deficiency and intracranial hemorrhage. Coagulation screening combined with clinical manifestations was performed to diagnose congenital FV deficiency. Genetic testing was performed to identify the pathogenic genes. A literature review was included to emphasize the clinical manifestation, diagnosis, and treatment for congenital FV deficiency with intracranial bleeding.

Results: The coagulation tests revealed a significantly prolonged prothrombin time (PT) of 51 s and an activated partial thromboplastin time (APTT) of 73.7 s. The patient had a plasma FV activity of 0.9%. Genetic testing showed compound heterozygous mutations of the patient's FV gene. A literature review showed that patients with homozygous or compound heterozygous variants of the FV gene were often associated with a severe bleeding phenotype.

Conclusion: Our study provides a direction for the rapid and accurate diagnosis and treatment for FV deficiency to avoid life-threatening bleeding. Infants with spontaneous cranial hematoma and intracranial hemorrhage should be investigated for underlying hemostatic defects. Congenital coagulation factor deficiency should be considered. Once congenital FV deficiency is diagnosed, fresh frozen plasma (FFP) should be given on a regular basis. Liver transplantation may be performed in severe cases.

1. 1. Park CH, Park MS, Lee KO, Kim SH, Park YS, Kim HJ. Congenital factor V deficiency from compound heterozygous mutations with a novel variant c.2426del (p.Pro809Hisfs*2) in the F5 gene: a case report. Medicine. 2020;99(5):e18947. - PMC - PubMed
2. 1. Bernal S, Pelaez I, Alias L, et al. High mutational heterogeneity, and new mutations in the human coagulation factor V gene. Future perspectives for factor V deficiency using recombinant and advanced therapies. Int J Mol Sci. 2021;22(18):9705. - PMC - PubMed
3. 1. Tabibian S, Shiravand Y, Shams M, et al. A comprehensive overview of coagulation factor V and congenital factor V deficiency. Semin Thromb Hemost. 2019;45(5):523‐543. - PubMed
4. 1. Asselta R, Peyvandi F. Factor V deficiency. Semin Thromb Hemost. 2009;35(4):382‐389. - PubMed
5. 1. Meidert AS, Kinzinger J, Möhnle P, et al. Perioperative Management of a Patient with severe factor V deficiency presenting with chronic subdural hematoma: a clinical report. World Neurosurg. 2019;127:409‐413. - PubMed